McConaha CW - Search Results

1

Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.

Barbarich NC, McConaha CW, Halmi KA, Gendall K, Sunday SR, Gaskill J, La Via M, Frank GK, Brooks S, Plotnicov KH, Kaye WH. Barbarich NC, et al. Among authors: mcconaha cw. Int J Eat Disord. 2004 Jan;35(1):10-5. doi: 10.1002/eat.10235. Int J Eat Disord. 2004. PMID: 14705152 Clinical Trial.

2

Anxiolytic effects of acute tryptophan depletion in anorexia nervosa.

Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M, McConaha CW, Kishore A. Kaye WH, et al. Among authors: mcconaha cw. Int J Eat Disord. 2003 Apr;33(3):257-67; discussion 268-70. doi: 10.1002/eat.10135. Int J Eat Disord. 2003. PMID: 12655621 Clinical Trial.

3

An open trial of olanzapine in anorexia nervosa.

Barbarich NC, McConaha CW, Gaskill J, La Via M, Frank GK, Achenbach S, Plotnicov KH, Kaye WH. Barbarich NC, et al. Among authors: mcconaha cw. J Clin Psychiatry. 2004 Nov;65(11):1480-2. doi: 10.4088/jcp.v65n1106. J Clin Psychiatry. 2004. PMID: 15554759 Clinical Trial.

4

Olanzapine treatment of anorexia nervosa: a retrospective study.

Malina A, Gaskill J, McConaha C, Frank GK, LaVia M, Scholar L, Kaye WH. Malina A, et al. Int J Eat Disord. 2003 Mar;33(2):234-7. doi: 10.1002/eat.10122. Int J Eat Disord. 2003. PMID: 12616591 Clinical Trial.

5

Personality traits after recovery from eating disorders: do subtypes differ?

Wagner A, Barbarich-Marsteller NC, Frank GK, Bailer UF, Wonderlich SA, Crosby RD, Henry SE, Vogel V, Plotnicov K, McConaha C, Kaye WH. Wagner A, et al. Int J Eat Disord. 2006 May;39(4):276-84. doi: 10.1002/eat.20251. Int J Eat Disord. 2006. PMID: 16528697

6

Laxative withdrawal and anxiety in bulimia nervosa.

Weltzin TE, Bulik CM, McConaha CW, Kaye WH. Weltzin TE, et al. Among authors: mcconaha cw. Int J Eat Disord. 1995 Mar;17(2):141-6. doi: 10.1002/1098-108x(199503)17:2<141::aid-eat2260170206>3.0.co;2-5. Int J Eat Disord. 1995. PMID: 7757094

7

Altered dopamine activity after recovery from restricting-type anorexia nervosa.

Kaye WH, Frank GK, McConaha C. Kaye WH, et al. Neuropsychopharmacology. 1999 Oct;21(4):503-6. doi: 10.1016/S0893-133X(99)00053-6. Neuropsychopharmacology. 1999. PMID: 10481833

8

Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.

Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C, Plotnicov KH, Weise J, Deep D. Kaye WH, et al. Biol Psychiatry. 2001 Apr 1;49(7):644-52. doi: 10.1016/s0006-3223(00)01013-1. Biol Psychiatry. 2001. PMID: 11297722 Clinical Trial.

9

Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration.

Frank GK, Kaye WH, Weltzin TE, Perel J, Moss H, McConaha C, Pollice C. Frank GK, et al. Int J Eat Disord. 2001 Jul;30(1):57-68. doi: 10.1002/eat.1054. Int J Eat Disord. 2001. PMID: 11439409 Clinical Trial.

10

Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.

Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, McConaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH. Bailer UF, et al. Among authors: mcconaha cw. Neuropsychopharmacology. 2004 Jun;29(6):1143-55. doi: 10.1038/sj.npp.1300430. Neuropsychopharmacology. 2004. PMID: 15054474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters